Developer docs
API playgroundTry for free, no card

Search company profiles

Syntheon

Full company profile

uuid00029gb

Namestring
Syntheon
Legal namestring
Syntheon LLC
Websiteurl
syntheon.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Syntheon LLC is a Miami, Florida-based medical device incubator founded in 1999 that invents, develops, prototypes, and manufactures electromechanical medical devices for subsequent licensing, sale, or co-development with major medical device OEMs. The company operates from a 35,000 sq. ft. facility that includes modeling design stations, PCB assembly, 3D printing, CNC and standard machining, a fluoroscopy-equipped clinical lab, and a 5,000 sq. ft. manufacturing clean room, allowing it to take a concept from ideation through clinical-trial-ready or commercial manufacturing in-house. Its technology portfolio spans cardiology, interventional neurology, and surgical/endoscopic devices, anchored by over 200 issued patents developed by the principals and a 100-year combined product development experience base.

Syntheon's business model is a hybrid of three revenue streams: (1) outright technology licensing and acquisition sales to large OEMs such as Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Olympus, Medtronic, and Covidien; (2) risk-and-reward-sharing co-development partnerships where Syntheon develops products identified as market needs by partner companies; and (3) direct manufacturing and sale of products through subsidiary entities using its in-house clean room capacity. Its most prominent commercial product to date is the Penditure Left Atrial Appendage Exclusion System, an innovative implantable cardiac surgery clip that is the only LAA clip capable of recapture, repositioning, and redeployment after deployment, which was acquired by Medtronic in August 2023 and commercially launched in the U.S. later that year. Customers served are exclusively large enterprise medical device manufacturers; end beneficiaries are patients (over 52 million cumulatively, by the company's count) treated with products developed by Syntheon principals. Pricing is not publicly disclosed and operates on a custom, quote-based B2B engagement model.

Short descriptiontext

Syntheon LLC is a Miami-based medical device incubator that invents, prototypes, and manufactures electromechanical medical devices for licensing, sale, or co-development with major medical device OEMs, holding over 200 patents across cardiology and surgery.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device incubation, cardiac surgery devices, medical device licensing, electromechanical medical devices, medical device manufacturing
Industry1 code
PRIMARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Medical Device Development
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Technology Licensing and Acquisition
TypeLicensing Royalties
Description

Syntheon develops medical device technologies and sells or licenses proprietary technologies to major medical device companies. Companies such as Johnson & Johnson, Boston Scientific, Edwards, Olympus, and others have acquired Syntheon's proprietary technologies.

syntheon.com
2Co-development Partnerships
TypeProfessional Services
Description

Working with medical device companies that identify market needs, Syntheon develops new products from initial innovation through final manufacturing, sharing both risk and reward with partners.

syntheon.com
3Manufacturing Operations
TypeHardware Sales
Description

Products manufactured through subsidiary entities, leveraging in-house 35,000 sq. ft facility with manufacturing clean room capabilities.

syntheon.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Infrastructure, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Syntheon is a medical device incubator that invents, develops, and manufactures innovative electro-mechanical medical devices. The company partners with major medical device companies through co-development, technology licensing, and acquisition arrangements, bringing products from initial innovation through clinical trials and final manufacturing. Products are either licensed or sold to industry partners such as Medtronic, Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Olympus, and Covidien, or brought to market through subsidiary entities using its 35,000 sq. ft. Miami facility with in-house prototyping, clean room manufacturing, and clinical lab capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 52+ million patients improved through Syntheon-developed products
+2 more records
Product overview1 text field

Syntheon is a medical device incubator that invents and develops innovative medical devices for unmet clinical needs. The company leverages over 200 issued patents and 100 years of product development experience to create patented electro-mechanical medical devices. Their portfolio includes the Penditure™ Left Atrial Appendage Exclusion System, which was acquired by Medtronic in 2023. Syntheon operates from a 35,000 sq. ft. state-of-the-art facility in Miami, Florida with in-house capabilities including modeling design stations, PCB assembly, programming, 3D printing, CNC machining, clinical lab with fluoroscopy, and a 5,000 sq. ft. manufacturing clean room.

Product and service2 records
1Penditure Left Atrial Appendage Exclusion System
CategoryCardiac Medical Devices
Description

An innovative implantable clip pre-loaded on a single-use delivery system for left atrial appendage management during cardiac surgery. The curved clip matches atrial anatomy, is designed without fabric for atraumatic closure and reduced inflammation, and is the only LAA clip that can be recaptured, repositioned, and redeployed after deployment. The technology was acquired by Medtronic in August 2023.

2Medical Device Development, Co-Development, and Technology Licensing Services
CategoryMedical Device Development Services
Description

Comprehensive medical device incubator services spanning initial innovation, rapid prototyping, testing, and final manufacturing. Syntheon partners with major medical device companies through co-development engagements that share risk and reward, licenses or sells proprietary technologies, and brings products to market through subsidiary entities. The offering leverages in-house capabilities including 3D printing, CNC machining, PCB assembly, a clinical lab with fluoroscopy, and a 5,000 sq. ft. clean room manufacturing facility.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-08-01
Description

Medtronic completed the acquisition of the Penditure Left Atrial Appendage Exclusion System technology from Syntheon LLC in August 2023. The acquisition expands Medtronic's Cardiac Surgery portfolio to include left atrial appendage management. The first cases were performed by Drs. Gorav Ailawadi and Basel Ramlawi at the University of Michigan Frankel Cardiovascular Center and Lankenau Heart Institute.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Johnson & Johnson (including subsidiary Ethicon) has acquired proprietary technologies from Syntheon, representing a long-term partnership in medical device development.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Boston Scientific has acquired Syntheon proprietary technologies, representing a significant partnership in the interventional medical device space.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Edwards Lifesciences has acquired proprietary technologies from Syntheon, indicating a partnership in cardiac device innovation.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Olympus has acquired Syntheon proprietary technologies, representing a partnership in endoscopic and surgical device development.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Covidien (now part of Medtronic) has acquired proprietary technologies from Syntheon, indicating a historical partnership in medical device development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Conformal Medical develops next-generation left atrial appendage (LAA) closure devices — directly competitive with Syntheon's Penditure clip in the same cardiac surgery procedure category. Comparable as an early-to-mid-stage medical device innovator targeting strategic acquisition by major medtech acquirers.

TypeDirect peer
Description

Corvia Medical developed the InterAtrial Shunt Device (IASD) for heart failure with preserved ejection fraction. Comparable as a clinical-stage structural heart device innovator pursuing partner-driven commercialization.

TypeEmerging player
Description

REVA Medical developed bioresorbable polymer scaffolds for vascular applications. Comparable through its small-team medical device innovator profile targeting cardiovascular procedure markets through strategic partner channels.

TypeDirect peer
Description

JenaValve develops transcatheter aortic valve replacement (TAVR) systems and operates as a clinical-stage medical device innovator partnering with major cardiac medtech players. Comparable through its structural heart focus, IP-driven differentiation, and reliance on strategic partners for commercialization.

TypeDirect peer
Description

Cardiac Dimensions develops the Carillon mitral contour system for functional mitral regurgitation, operating as a structural heart device innovator. Comparable to Syntheon through its focus on cardiac surgery innovation and partner-driven commercialization pathway.

6Intact Vascular (acquired by Philips)
TypeDirect peer
Description

Intact Vascular developed the Tack Endovascular System for peripheral arterial disease and was ultimately acquired by Philips. Closely comparable exit pathway to Syntheon's model of building specialized vascular devices for strategic acquisition by larger medtech.

7Aria CV
TypeEmerging player
Description

Aria CV is developing an implantable pulmonary artery sensor system for pulmonary hypertension, operating as an early-stage structural heart/pulmonary device innovator. Comparable through its pursuit of strategic partnership/acquisition pathways in the cardiology space.

TypeDirect peer
Description

Svelte Medical Systems developed a low-profile drug-eluting stent delivery system acquired by Integer Holdings. Comparable as a small-team medical device innovator whose proprietary technology was ultimately licensed/divested to a larger medtech partner.

9Foundry Medical Innovations
TypeDirect peer
Description

Foundry Medical Innovations operates as a medical device incubator developing innovations across cardiovascular and other specialties for licensing to strategic partners. Directly comparable business model to Syntheon's incubator approach.

TypeDirect peer
Description

SentreHEART developed LAA closure technology acquired by AtriCure, mirroring Syntheon's exit path of licensing/divesting novel structural heart technology to a larger cardiac medtech player. Operates in the same clinical procedure category (left atrial appendage management).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syntheon

Medical Device Developmentsyntheon.com

Syntheon LLC is a Miami-based medical device incubator that invents, prototypes, and manufactures electromechanical medical devices for licensing, sale, or co-development with major medical device OEMs, holding over 200 patents across cardiology and surgery.

What Syntheon does

Syntheon LLC is a Miami, Florida-based medical device incubator founded in 1999 that invents, develops, prototypes, and manufactures electromechanical medical devices for subsequent licensing, sale, or co-development with major medical device OEMs. The company operates from a 35,000 sq. ft. facility that includes modeling design stations, PCB assembly, 3D printing, CNC and standard machining, a fluoroscopy-equipped clinical lab, and a 5,000 sq. ft. manufacturing clean room, allowing it to take a concept from ideation through clinical-trial-ready or commercial manufacturing in-house. Its technology portfolio spans cardiology, interventional neurology, and surgical/endoscopic devices, anchored by over 200 issued patents developed by the principals and a 100-year combined product development experience base.

Syntheon's business model is a hybrid of three revenue streams: (1) outright technology licensing and acquisition sales to large OEMs such as Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Olympus, Medtronic, and Covidien; (2) risk-and-reward-sharing co-development partnerships where Syntheon develops products identified as market needs by partner companies; and (3) direct manufacturing and sale of products through subsidiary entities using its in-house clean room capacity. Its most prominent commercial product to date is the Penditure Left Atrial Appendage Exclusion System, an innovative implantable cardiac surgery clip that is the only LAA clip capable of recapture, repositioning, and redeployment after deployment, which was acquired by Medtronic in August 2023 and commercially launched in the U.S. later that year. Customers served are exclusively large enterprise medical device manufacturers; end beneficiaries are patients (over 52 million cumulatively, by the company's count) treated with products developed by Syntheon principals. Pricing is not publicly disclosed and operates on a custom, quote-based B2B engagement model.

Syntheon firmographics

Firmographics
Name
Syntheon
Legal name
Syntheon LLC
Website
https://syntheon.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Syntheon LLC is a Miami-based medical device incubator that invents, prototypes, and manufactures electromechanical medical devices for licensing, sale, or co-development with major medical device OEMs, holding over 200 patents across cardiology and surgery.
Ownership category
akta.pro rank

Syntheon industry classification

Industry
Product category
Medical Device Development
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Medical device incubation
  • Cardiac surgery devices
  • Medical device licensing
  • Electromechanical medical devices
  • Medical device manufacturing

Where Syntheon is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Syntheon business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Technology Licensing and Acquisition: Syntheon develops medical device technologies and sells or licenses proprietary technologies to major medical device companies. Companies such as Johnson & Johnson, Boston Scientific, Edwards, Olympus, and others have acquired Syntheon's proprietary technologies.
  2. Co-development Partnerships: Working with medical device companies that identify market needs, Syntheon develops new products from initial innovation through final manufacturing, sharing both risk and reward with partners.
  3. Manufacturing Operations: Products manufactured through subsidiary entities, leveraging in-house 35,000 sq. ft facility with manufacturing clean room capabilities.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Syntheon product offering

Product offering

Core offering

Syntheon is a medical device incubator that invents, develops, and manufactures innovative electro-mechanical medical devices. The company partners with major medical device companies through co-development, technology licensing, and acquisition arrangements, bringing products from initial innovation through clinical trials and final manufacturing. Products are either licensed or sold to industry partners such as Medtronic, Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Olympus, and Covidien, or brought to market through subsidiary entities using its 35,000 sq. ft. Miami facility with in-house prototyping, clean room manufacturing, and clinical lab capabilities.

Product overview

Syntheon is a medical device incubator that invents and develops innovative medical devices for unmet clinical needs. The company leverages over 200 issued patents and 100 years of product development experience to create patented electro-mechanical medical devices. Their portfolio includes the Penditure™ Left Atrial Appendage Exclusion System, which was acquired by Medtronic in 2023. Syntheon operates from a 35,000 sq. ft. state-of-the-art facility in Miami, Florida with in-house capabilities including modeling design stations, PCB assembly, programming, 3D printing, CNC machining, clinical lab with fluoroscopy, and a 5,000 sq. ft. manufacturing clean room.

Differentiator

Problem solved

Functional benefit

Products and services

  • Penditure Left Atrial Appendage Exclusion System An innovative implantable clip pre-loaded on a single-use delivery system for left atrial appendage management during cardiac surgery. The curved clip matches atrial anatomy, is designed without fabric for atraumatic closure and reduced inflammation, and is the only LAA clip that can be recaptured, repositioned, and redeployed after deployment. The technology was acquired by Medtronic in August 2023.
  • Medical Device Development, Co-Development, and Technology Licensing Services Comprehensive medical device incubator services spanning initial innovation, rapid prototyping, testing, and final manufacturing. Syntheon partners with major medical device companies through co-development engagements that share risk and reward, licenses or sells proprietary technologies, and brings products to market through subsidiary entities. The offering leverages in-house capabilities including 3D printing, CNC machining, PCB assembly, a clinical lab with fluoroscopy, and a 5,000 sq. ft. clean room manufacturing facility.

Quantifiable outcome

  • 52+ million patients improved through Syntheon-developed products
  • +2 more outcomes

Companies that use Syntheon

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Syntheon technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Syntheon partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • MedtroniccoreOEM/ Whitelabel/ Licensing Partner · 1 August 2023Medtronic completed the acquisition of the Penditure Left Atrial Appendage Exclusion System technology from Syntheon LLC in August 2023. The acquisition expands Medtronic's Cardiac Surgery portfolio to include left atrial appendage management. The first cases were performed by Drs. Gorav Ailawadi and Basel Ramlawi at the University of Michigan Frankel Cardiovascular Center and Lankenau Heart Institute.
  • Johnson & JohnsoncoreOEM/ Whitelabel/ Licensing PartnerJohnson & Johnson (including subsidiary Ethicon) has acquired proprietary technologies from Syntheon, representing a long-term partnership in medical device development.
  • Boston ScientificcoreOEM/ Whitelabel/ Licensing PartnerBoston Scientific has acquired Syntheon proprietary technologies, representing a significant partnership in the interventional medical device space.
  • Edwards LifesciencescoreOEM/ Whitelabel/ Licensing PartnerEdwards Lifesciences has acquired proprietary technologies from Syntheon, indicating a partnership in cardiac device innovation.
  • OlympuscoreOEM/ Whitelabel/ Licensing PartnerOlympus has acquired Syntheon proprietary technologies, representing a partnership in endoscopic and surgical device development.
  • CovidiencoreOEM/ Whitelabel/ Licensing PartnerCovidien (now part of Medtronic) has acquired proprietary technologies from Syntheon, indicating a historical partnership in medical device development.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Syntheon competitors and assessment

Company assessment

Direct peers

  • Conformal Medical: Conformal Medical develops next-generation left atrial appendage (LAA) closure devices — directly competitive with Syntheon's Penditure clip in the same cardiac surgery procedure category. Comparable as an early-to-mid-stage medical device innovator targeting strategic acquisition by major medtech acquirers.
  • Corvia Medical: Corvia Medical developed the InterAtrial Shunt Device (IASD) for heart failure with preserved ejection fraction. Comparable as a clinical-stage structural heart device innovator pursuing partner-driven commercialization.
  • JenaValve Technology: JenaValve develops transcatheter aortic valve replacement (TAVR) systems and operates as a clinical-stage medical device innovator partnering with major cardiac medtech players. Comparable through its structural heart focus, IP-driven differentiation, and reliance on strategic partners for commercialization.
  • Cardiac Dimensions: Cardiac Dimensions develops the Carillon mitral contour system for functional mitral regurgitation, operating as a structural heart device innovator. Comparable to Syntheon through its focus on cardiac surgery innovation and partner-driven commercialization pathway.
  • Intact Vascular (acquired by Philips): Intact Vascular developed the Tack Endovascular System for peripheral arterial disease and was ultimately acquired by Philips. Closely comparable exit pathway to Syntheon's model of building specialized vascular devices for strategic acquisition by larger medtech.
  • Svelte Medical Systems: Svelte Medical Systems developed a low-profile drug-eluting stent delivery system acquired by Integer Holdings. Comparable as a small-team medical device innovator whose proprietary technology was ultimately licensed/divested to a larger medtech partner.
  • Foundry Medical Innovations: Foundry Medical Innovations operates as a medical device incubator developing innovations across cardiovascular and other specialties for licensing to strategic partners. Directly comparable business model to Syntheon's incubator approach.
  • SentreHEART: SentreHEART developed LAA closure technology acquired by AtriCure, mirroring Syntheon's exit path of licensing/divesting novel structural heart technology to a larger cardiac medtech player. Operates in the same clinical procedure category (left atrial appendage management).

Emerging players

  • REVA Medical: REVA Medical developed bioresorbable polymer scaffolds for vascular applications. Comparable through its small-team medical device innovator profile targeting cardiovascular procedure markets through strategic partner channels.
  • Aria CV: Aria CV is developing an implantable pulmonary artery sensor system for pulmonary hypertension, operating as an early-stage structural heart/pulmonary device innovator. Comparable through its pursuit of strategic partnership/acquisition pathways in the cardiology space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Syntheon social profiles

Digital presence

Syntheon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syntheon leadership team

Management profile

Number of profiles

Profiles6 records

Syntheon funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syntheon M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syntheon

What does Syntheon do?

Syntheon is a medical device incubator that invents, develops, and manufactures innovative electro-mechanical medical devices. The company partners with major medical device companies through co-development, technology licensing, and acquisition arrangements, bringing products from initial innovation through clinical trials and final manufacturing. Products are either licensed or sold to industry partners such as Medtronic, Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Olympus, and Covidien, or brought to market through subsidiary entities using its 35,000 sq. ft. Miami facility with in-house prototyping, clean room manufacturing, and clinical lab capabilities.

Is Syntheon a public or private company?

Syntheon is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Syntheon founded?

Syntheon was founded in 1999. It employs 11 to 50 people.

Where is Syntheon based?

Syntheon is headquartered in Miami, United States, in the North America region.

How does Syntheon make money?

Three revenue lines are on record. Technology Licensing and Acquisition is the primary driver. The others are co-development Partnerships and manufacturing Operations.

Who are Syntheon's main competitors?

Direct peers on record are Conformal Medical, Corvia Medical, JenaValve Technology, Cardiac Dimensions, Intact Vascular (acquired by Philips), Svelte Medical Systems, Foundry Medical Innovations and SentreHEART. Emerging players are REVA Medical and Aria CV.

Does Syntheon have an API?

No public API is recorded for Syntheon.

What industry is Syntheon in?

Syntheon's product category is Medical Device Development. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO). Its NAICS code is 339112 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magRapidPulse Pockets $48 Million for Stroke Aspiration Tech DevelopmentRapidPulse closed a $48 million Series B round co-led by Medtronic, TechWald, and S3 Ventures. The financing will complete its TURBO study and expand clinical experience, with potential FDA approval if data permits.Venture Capital Access OnlineRapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration TechnologyRapidPulse closed a $48 million Series B financing co-led by Medtronic, TechWald Next, and S3 Ventures. The funds will support its TURBO study and expansion of its pulsed aspiration technology. The company aims to seek FDA approval for its system.GlobeNewswireRapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke TherapyRapidPulse closed a $15 million Series A financing led by Santé Ventures, with participation from Epidarex Capital, Hatteras Venture Partners, Broadview Ventures, and Syntheon. The company will use the funds to advance its RapidPulse Cyclic Aspiration System through expanded clinical evaluation and build its proprietary catheter platform.Venture Capital Access OnlineRapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke TherapyRapidPulse, a privately held medical device company developing a cyclic aspiration system for ischemic stroke, announced on June 23, 2021 the closing of a $15 million Series A led by Santé Ventures, with participation from Epidarex Capital, Hatteras Venture Partners, Broadview Ventures and Syntheon. The company will use the funds for expanded clinical evaluation and proprietary catheter development, with U.S. regulatory approval targeted.